Skip to content

Oral six-month treatment for MDR-TB is safe and effective in people with HIV

Dr Louisa Dunn, a sub-investigator on the TB PRACTECAL clinical trial consults with a patient in South Africa. Photo by MSF.

Barcelona woman controls HIV for over 15 years without treatment

Dr Núria Climent at AIDS 2022.

Trans people left out of many countries’ strategic HIV plans

The Trans Inclusion in National HIV Policy and Planning session panel at AIDS 2022. Photo by @GATEOrg.

Who, what, where and when: tailoring PrEP services to increase uptake

Dr Narukjaporn Thammajaruk at AIDS 2022. Photo©Marcus Rose/IAS

HIV test-and-treat reduces TB incidence in the community

Dr Carina Marquez at AIDS 2022. Photo: Roger Pebody

Minimal antibody response in Imbokodo compels change of course for HIV vaccine research

Dr Avi Kenny at AIDS 2022. Photo ©Steve Forrest/Workers’ Photos/IAS

Biktarvy combination pill may be most effective option for people with HIV and hepatitis B

Dr Anchalee Avihingsanon at AIDS 2022. Photo ©Steve Forrest/Workers’ Photos/IAS

Educating police on harm reduction can help to prevent HIV and fatal overdoses

Dr Javier Cepeda at AIDS 2022. Photo ©Jordi Ruiz Cirera/IAS.

Smart new single-cell assay shines a light on the HIV reservoir

Dr Eli Boritz at AIDS 2022. Photo ©Steve Forrest/Workers’ Photos/IAS